

Modafinil (CAS 68693-11-8) serves as a critical active pharmaceutical ingredient in the neuro-therapeutics sector, primarily indicated for narcolepsy and sleep-wake disorders. In this field, CDMOs are increasingly focusing on high-purity fine chemicals (Pharma/API purity 99% | General Industry purity 98%) to ensure optimal bioavailability and safety profiles. 2-[(Diphenylmethyl)sulfinyl]acetamide (CAS 68693-11-8) is witnessing a significant shift in the API intermediates market as global sourcing strategies evolve to prioritize suppliers who offer custom synthesis services with robust analytical validation to meet stringent EMA and FDA regulatory standards. Benzhydrylsulfinylacetamide (CAS 68693-11-8) remains a high-demand compound for bulk chemical suppliers, driven by the expanding global market for cognitive enhancers and the necessity for manufacturers to provide comprehensive impurity profiling and GMP-compliant documentation to facilitate large-scale commercial manufacturing. As an established global API supplier, we provide >= 99% purity for semi-finished formulators, comprehensive analytical testing (HPLC/NMR/MS), and Modafinil COA/TDS/SDS documentation. Our services include region-specific regulatory support, reliable lead times, and worldwide supply chain capabilities.

Modafinil (CAS 68693-11-8) serves as a critical active pharmaceutical ingredient in the neuro-therapeutics sector, primarily indicated for narcolepsy and sleep-wake disorders. In this field, CDMOs are increasingly focusing on high-purity fine chemicals (Pharma/API purity 99% | General Industry purity 98%) to ensure optimal bioavailability and safety profiles. 2-[(Diphenylmethyl)sulfinyl]acetamide (CAS 68693-11-8) is witnessing a significant shift in the API intermediates market as global sourcing strategies evolve to prioritize suppliers who offer custom synthesis services with robust analytical validation to meet stringent EMA and FDA regulatory standards. Benzhydrylsulfinylacetamide (CAS 6...

Chemical Properties & Specifications
P201, P202, P260, P264, P270, P271, P280, P301+P312, P330, P304+P340, P308+P313, P314, P405, and P501
Repr. 2 (100%)
STOT RE 2 (100%)
A central nervous system stimulant indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea, or shift work disorder
A pharmaceutical nootropic agent used off-label to enhance executive functions such as planning, decision-making, and fluid intelligence in healthy individuals
A secondary treatment used alongside continuous positive airway pressure (CPAP) machines to manage residual daytime sleepiness in patients with obstructive sleep apnea
A clinical intervention used off-label to mitigate debilitating fatigue associated with medical conditions such as multiple sclerosis, major depressive disorder, and certain cancers.
Modafinil is a central nervous system stimulant and wakefulness-promoting agent used to treat excessive sleepiness caused by narcolepsy, shift work sleep disorder, and obstructive sleep apnea
This compound is primarily used in the pharmaceutical and healthcare industries for the treatment of sleep disorders and as an off-label cognitive enhancer
Modafinil is practically insoluble in water and is typically formulated as oral tablets, including fast-dissolving and direct-compression tablets
Standard specifications include CAS number 68693-11-8, high purity typically verified by HPLC, and documentation such as COA, TDS, impurity reports, and regulatory compliance documents
Scimplify has capabilities for global distribution and custom synthesis through an integrated network of manufacturers and logistics partners with reliable lead time
The product is export ready with a standard MOQ starting from 100 kgs, with lead times for international customers depending on the shipping destination and specific grade.
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : P-Nitrobenzoyl Chloride (CAS 122-04-3) is a critical building block in the API intermediates market,...